 Your new post is loading...
Hedge Funds improved on losses of 2.69% in January but still posted negative performance of -0.06% in February.
Index to Promote Gender Diversity announced by SSGA. Positive development. Take action: request that SSGA also vote its proxies to promote gender diversity.
In February 2016, the SEC warned that among a broad selection of companies, poorly-drafted, ambiguous and sometimes incorrect proxy disclosure for the method by which votes will be counted for director elections may necessitate new, tougher disclosure rules. [1] This post offers guidance on how to avoid the most common proxy drafting pitfalls and provides tips on drafting disclosure that is both precise and compliant with proxy rules.
Royce Micro-Cap Opportunity Fund's Letter to Shareholders, Stocks: PSIX,ZUMZ,EXAR,CENX,TNGO,USCR,ELNK,BLDR,RTI,AAOI, release date:Mar 14, 2016
The company, which is facing inquiries over its drug-pricing policies, had previously delayed the release of its earnings.
In this paper, we therefore reconsider the problem of hedge fund diversification. Our approach relies on the naïve diversification strategies
Last month, the Federal Trade Commission challenged a $5 million acquisition in the pharmaceutical industry. The FTC’s challenge serves as a reminder that no deal is too small to generate scrutiny from the U.S. antitrust agencies. During the Obama administration, the FTC and Department of Justice have devoted significant resources to investigating and challenging transactions that are not subject to the reporting requirements of the Hart-Scott-Rodino Act, including consummated transactions. [1] The FTC’s latest challenge shows that a low purchase price or the lack of an HSR filing obligation does not exempt a transaction from antitrust scrutiny.
On February 5, 2016, the New York Stock Exchange (“NYSE”) filed with the Securities and Exchange Commission (“SEC”) a proposed rule change that would require listed foreign private issuers to submit a Form 6-K to the SEC with unaudited financial information at least semi-annually. [1] On February 19, 2016, the SEC designated the proposed rule change “operative upon filing,” waiving the 30-day operative delay typically associated with proposed rule changes by self-regulatory organizations. [2]
Sixty-five hearings were completed, with total fines of nearly $5.4 million imposed. The MFDA collected $843,982 of that amount
It wasn’t easy but two bad situations have been created from one
Yahoo’s appointment of two new board members Thursday signals the Internet company is girding to battle activist investors over its future.
|
The redistribution effect offers an alternative explanation for many of the adverse attributes of OTC markets in the post-TRACE era.
SEC Nods to Multinationals
At the end of another record-breaking year for shareholder activism activity, it is appropriate that we ring in the publication of this, the inaugural edition of Shareholder Activism & Engagement, part of the Getting the Deal Through series.
Valeant cited slower growth in its U.S. dermatology, gastrointestinal and women's health businesses for the cut
Genworth Financial has agreed to pay to end a class-action lawsuit for allegedly making false and misleading statements
Many prominent business executives and legal scholars are convinced that the American economy will suffer unless hedge fund activism with its perceived “short-termism” agenda is significantly restricted.
Have Shareholder Rights Gone Too Far? TK Kerstetter interviews James McRitchie. Shareholder rights still needed. Funds should disclose proxy votes earlier.
The FDIC has resolved hundreds of banks since the crisis, in nearly all cases making insured deposits available to the failed bank’s customers by the next business day. Although US depositors have come to rely on the efficiency and seamlessness of this process, the work that goes on behind the scenes to determine exactly which deposits are insured (and for how much) can be very complex.
Michael Pearson, CEO Valeant Pharmaceuticals, sent word last month that he was ready to return from a lengthy medical leave. But not all of the drugmaker’s directors were sure they wanted him back.
Companies are wise to act quickly in such circumstances, rather than wait for serious allegations to play out in a court of law or public opinion, an associate professor says
The SEC announces charges against a California business man alleged to have stolen investor funds and attempted to cover up the theft.
|
Scoop.it!
